Peer-reviewedLicence not statedPsychopharmacology Bulletin
Bupropion-Induced Aseptic Meningitis: Postmarketing Safety Evaluation and Case Report
Related
- Aseptic Meningitis Unmasking Coccidioidomycosis of the Central Nervous System Outside an Endemic Region
- Guiding neurosurgical intervention in tuberculous meningitis: evaluation of clinical features, laboratory parameters, and outcomes with a treatment algorithm
- Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan
- Bridging Nonconsecutive Esketamine Weeks with Bupropion and Over-the-Counter Dextromethorphan
- Early postmarketing reporting patterns of resmetirom in FAERS: disproportionality analyses with indication-restricted and active comparators
BibTeX
@article{cusimano2026bupropioninduced,
title = {{Bupropion-Induced Aseptic Meningitis: Postmarketing Safety Evaluation and Case Report}},
author = {Joseph Cusimano and David Croteau and Jamie Ridley Klucken and Henry Appiah and Sheheryar Muhammad and Rajdeep Gill and Shamir Kalaria and Vicky Chan},
journal = {Psychopharmacology Bulletin},
year = {2026},
month = oct,
doi = {10.64719/pb.21591},
url = {https://doi.org/10.64719/pb.21591},
}
RIS
TY - JOUR
TI - Bupropion-Induced Aseptic Meningitis: Postmarketing Safety Evaluation and Case Report
AU - Joseph Cusimano
AU - David Croteau
AU - Jamie Ridley Klucken
AU - Henry Appiah
AU - Sheheryar Muhammad
AU - Rajdeep Gill
AU - Shamir Kalaria
AU - Vicky Chan
PY - 2026
DA - 2026/10/30
JO - Psychopharmacology Bulletin
DO - 10.64719/pb.21591
UR - https://doi.org/10.64719/pb.21591
SN - 0048-5764
SN - 2472-2448
ER -